Captrust Financial Advisors Atai Life Sciences N.V. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$3.03 - $5.32 $1,008 - $1,771	333 Added 162.44%	538 $2,000
Q1 2022 May 16, 2022	BUY	$4.66 - $7.66 $466 - $766	100 Added 95.24%	205 $1,000
Q4 2021 Feb 14, 2022	BUY	$6.82 - $17.8 $170 - $445	25 Added 31.25%	105 $1,000
Q2 2021 Aug 16, 2021	BUY	$16.94 - $19.89 $1,355 - $1,591	80 New	80 $1,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.